Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Affordable Made-in-India Microspheres for Liver Cancer Therapy [Phase 1]
A Phase 1 clinical trial in India is planned to evaluate microsphere-based therapy for hepatocellular carcinoma, with status listed as not y…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] [Phase 2]
Phase 2 clinical study of LBL-024 in combination therapy for advanced solid tumors is currently recruiting, with substudy focusing on biliar…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy [Phase 2]
This document announces a Phase 2 clinical trial evaluating PULSAR in combination with fecal microbiota transplantation for advanced hepatoc…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities [Phase 2]
A Phase 2 clinical trial evaluating whether ondansetron can reduce immune checkpoint inhibitor–related toxicities in hepatocellular carcinom…
-
CLINICAL_TRIALS other · 2026-03-11Clinical Trial Update: Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC) [NA]
A clinical trial currently recruiting to compare outpatient versus inpatient care pathways for intra-arterial treatment of primary liver can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
A post-marketing surveillance study in Japan evaluating the combination of durvalumab (Imfinzi) and tremelimumab (Imjudo) for unresectable h…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection [Phase 3]
A Phase 3 trial is evaluating neoadjuvant immunotherapy to enhance anti-tumor immunity in patients with hepatocellular carcinoma undergoing …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial assessing safety of the atezolizumab-bevacizumab combination in liver transplant recipients with advanced hepatocellu…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment [NA]
A clinical trial evaluating abbreviated MRI with gadoxetic acid versus CT for surveillance of recurrent hepatocellular carcinoma after curat…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy [Phase 2, Phase 3]
A phase 2/3 trial evaluated adding ipilimumab to the combination of atezolizumab and bevacizumab as first-line therapy for hepatocellular ca…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant [Phase 1]
This clinical trial update describes a Phase 1 imaging study using 18F-FSPG PET to evaluate liver cancer in patients scheduled for liver res…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AZD5851 in GPC3-positive advanced or recurrent hepatocellular carcinoma, with the study currently acti…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 [Phase 3]
A Phase 3 trial comparing regorafenib-pembrolizumab versus TACE/TARE in intermediate-stage hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning [NA]
This clinical trial update describes an ongoing study evaluating the fidelity between 99mTc-MAA and Y90-microspheres hepatic distribution fo…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies [NA]
A clinical trial from Fudan University investigating the safety, efficacy, and immune mechanisms of a combined multimodal tumor therapy for …
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors [Phase 1]
Phase 1 trial evaluating IL-15 armored glypican-3–specific CAR-T cells for solid tumors, including hepatocellular carcinoma and several pedi…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment [Phase 3]
A Phase 3 clinical trial evaluating durvalumab alone or with bevacizumab for hepatocellular carcinoma at high risk of recurrence after curat…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer [Phase 1, Phase 2]
Clinical trial update for a combination of nivolumab, fluorouracil, and interferon alfa-2b in unresectable fibrolamellar hepatocellular carc…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
This is an update on a multi-institutional registry study of patients with Hepatocellular Carcinoma undergoing liver transplantation. The st…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib [Phase 2]
A Phase 2 study evaluating intrabuccally administered electromagnetic fields in combination with regorafenib for hepatocellular carcinoma wa…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant atezolizumab plus bevacizumab before surgery for resectable hepatocellular carcinoma; the study is curr…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) [Phase 2]
A phase 2 exploratory trial studying the combination of atezolizumab and bevacizumab in hepatocellular carcinoma and metastatic non-small ce…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 2]
This is a completed Phase 2 clinical trial evaluating AK112 in patients with unresectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC
The completed trial examines whether CT features of microvascular invasion can predict response to transarterial chemoembolization plus a ty…